Fluocinolone acetonide intravitreal implant
Indication
Treating chronic diabetic macular oedema (NICE TA953)
Red
Brand:
Iluvien
Nice TA:
953
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Eye
Background
1.1 Fluocinolone acetonide intravitreal implant is recommended, within its marketing authorisation, as an option for treating visual impairment caused by chronic diabetic macular oedema that has not responded well enough to available treatments in adults. It is recommended only if the company provides it according to the commercial arrangement.